lilly direct tirzepatide vials launches lower-price weight-loss drug Zepbound without injector pen Eli Lilly to release single-dose

This study aimed to determine its role in mitigating diet-induced metabolic disorders, such as obesity, insulin resistance, and fatty liver disease, in ...

There is no silver bullet to weight loss or is there

Soaring use of these medications for weight loss is shifting demand, including for packaging manufacturers that serve pharma and food customers

Genetically-predicted GLP1R expression (the target of GLP-1 RAs) showed an inverse association with background [odds ratio (OR)=0.83, 95% CI, 0.710.97] and severe nonproliferative DR (OR=0.72, 95% CI, 0.530.98), and a non-significant association with overall (OR=0.97, 95% CI, 0.921.03) and proliferative DR (OR=0.98, 95% CI, 0.911.05)

Heart disease remains a critical issue in men and women with diabetes.

Compared to placebo, patients receiving liraglutide had significantly greater weight loss after 6-month therapy [MD6.0 kg (95% CI,8.66 to3.33)